000 | 01902 a2200541 4500 | ||
---|---|---|---|
005 | 20250514223734.0 | ||
264 | 0 | _c20051006 | |
008 | 200510s 0 0 eng d | ||
022 | _a1535-7163 | ||
024 | 7 |
_a10.1158/1535-7163.MCT-04-0130 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAyene, Iraimoudi S | |
245 | 0 | 0 |
_aKu protein targeting by Ku70 small interfering RNA enhances human cancer cell response to topoisomerase II inhibitor and gamma radiation. _h[electronic resource] |
260 |
_bMolecular cancer therapeutics _cApr 2005 |
||
300 |
_a529-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigens, Nuclear _xgenetics |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xpharmacology |
650 | 0 | 4 | _aApoptosis |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCricetinae |
650 | 0 | 4 | _aDNA Damage |
650 | 0 | 4 | _aDNA Repair |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 | _aDimerization |
650 | 0 | 4 | _aDose-Response Relationship, Radiation |
650 | 0 | 4 |
_aEtoposide _xpharmacology |
650 | 0 | 4 | _aGamma Rays |
650 | 0 | 4 | _aHeLa Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aKu Autoantigen |
650 | 0 | 4 | _aMicroscopy, Fluorescence |
650 | 0 | 4 |
_aNeoplasms _xtherapy |
650 | 0 | 4 | _aPhenotype |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aTelomere _xultrastructure |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTopoisomerase II Inhibitors |
650 | 0 | 4 | _aTransfection |
650 | 0 | 4 |
_aVDJ Recombinases _xmetabolism |
700 | 1 | _aFord, Lance P | |
700 | 1 | _aKoch, Cameron J | |
773 | 0 |
_tMolecular cancer therapeutics _gvol. 4 _gno. 4 _gp. 529-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-04-0130 _zAvailable from publisher's website |
999 |
_c15496075 _d15496075 |